Neurodevelopmental outcomes after red cell transfusion exposure in male versus female extremely preterm infants

Kendell German1, Thomas R Wood2, Semsa Gogcu3

  • 1University of Washington, Department of Pediatrics, Seattle, WA, USA. germank@uw.edu.

Pediatric Research
|June 2, 2025
PubMed

Insights

Sex may influence short-term cytokine responses to packed red blood cell (pRBC) transfusions in premature infants, but does not affect long-term neurodevelopmental outcomes. Transfusion volume is negatively associated with neurodevelopmental scores.

Area of Science:

  • Neonatal Medicine
  • Pediatric Neurology
  • Hematology

Background:

  • Packed red blood cell (pRBC) transfusions are critical for extremely premature infants.
  • pRBC transfusions are linked to increased pro-inflammatory cytokines and adverse neurodevelopment.
  • Potential sex differences in these transfusion-related effects are not well understood.

Purpose of the Study:

  • To investigate the association between pRBC transfusion volume and inflammatory cytokines, MRI-defined brain injury, and neurodevelopmental outcomes in extremely preterm infants.
  • To examine potential sex-specific differences in these associations.

Main Methods:

  • Post-hoc analysis of the Preterm Erythropoietin Neuroprotection (PENUT) Trial data.
  • Evaluation of associations between pRBC transfusion volume, cytokines (0-7 and 7-14 days), MRI injury, and Bayley Scales of Infant Development (BSID-III) scores at 24 months corrected age.
  • Use of graphical network and generalized estimating equation models to assess sex interactions and hematocrit influence.

Main Results:

  • Infant sex modified the association between pRBC transfusion volume and IL-6 levels at 7-14 days.
  • Sex did not impact the association between transfusion volume/hematocrit and BSID-III scores.
  • Total pRBC transfusion volume was significantly negatively associated with all BSID-III subscales, independent of anemia and illness severity.

Conclusions:

  • Infant sex may influence short-term cytokine responses to pRBC transfusions.
  • Sex does not appear to alter the relationship between transfusion volume and long-term neurodevelopmental outcomes.
  • Current evidence suggests transfusion practices should not be altered based on infant sex.
Abstract

Related Concept Videos

Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.9K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.3K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
821
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
509